Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Nutritional Intervention With Friliver for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome

NCT06814626 is registered in ClinicalTrials.gov with The Mediterranean Institute for Transplantation and Advanced Specialized Therapies as lead sponsor.

NCT NCT06814626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06814626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Nutritional Intervention With Friliver for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
Lead sponsor
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Phase
Phase 3
Overall status
Recruiting
Start date
October 13, 2022
Completion date
December 31, 2027
Enrollment
72 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, refractory ascites in patients with cirrhosis, sarcopenia in liver cirrhosis